Lena Andersch

Inhibiting Lysine Demethylase 1A Improves L1CAM-Specific CAR T Cell Therapy by Unleashing Antigen-Independent Killing via the FAS-FASL Axis

J. Schulte, A. Eggert, Anton G. Henssen, 2021, Cancers.

GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma

J. Schulte, A. Eggert, P. Hundsdoerfer, 2021, Journal for ImmunoTherapy of Cancer.

CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing

J. Schulte, A. Eggert, A. Joussen, 2019, BMC Cancer.

Combination of GD2-directed bispecific trifunctional antibody therapy with Pd-1 immune checkpoint blockade induces anti-neuroblastoma immunity in a syngeneic mouse model

J. Schulte, A. Eggert, P. Hundsdoerfer, 2023, Frontiers in Immunology.

A Reproducible Bioprinted 3D Tumor Model Serves as a Preselection Tool for CAR T Cell Therapy Optimization

F. Klironomos, J. Schulte, A. Eggert, 2021, Frontiers in Immunology.